We are live on ! Find out more
IRWD icon

Ironwood Pharmaceuticals
IRWD

212 hedge funds and large institutions have $2B invested in Ironwood Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 70 increasing their positions, 78 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

524% more call options, than puts

Call options by funds: $8.35M | Put options by funds: $1.34M

3.89% less ownership

Funds ownership: 108.92% → 105.03% (-3.9%)

7% less funds holding

Funds holding: 227 → 212 (-15)

10% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 78

14% less capital invested

Capital invested by funds: $2.31B → $2B (-$314M)

30% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 43

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
212
Holders Change
-15
Holders Change %
-6.61%
% of All Funds
3.26%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
30
Increased
70
Reduced
78
Closed
43
Calls
$8.35M
Puts
$1.34M
Net Calls
+$7.01M
Net Calls Change
-$3.26M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$23.3M
2
Norges Bank
Norges Bank
Norway
+$15.2M
3
ECM
ExodusPoint Capital Management
New York
+$6.99M
4
RA
Royce & Associates
New York
+$5.9M
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.76M

Top Sellers

Rank Fund Capital Flow
1
CCM
Camber Capital Management
Massachusetts
-$30.7M
2
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
-$22.2M
3
PI
Putnam Investments
Massachusetts
-$17.3M
4
UBS AM
UBS AM
Illinois
-$12.1M
5
BCM
Brown Capital Management
Maryland
-$9.16M
Name Holding Trade Value Shares
Change 		Change in
Stake
Wolverine Trading
226
Wolverine Trading
Illinois
– -$265K -21,606 Closed
BFM
227
Boothbay Fund Management
New York
– -$247K -18,929 Closed
SAM
228
Sawgrass Asset Management
Florida
– -$241K -18,420 Closed
SG Americas Securities
229
SG Americas Securities
New York
– -$215K -16,458 Closed
CC
230
Centiva Capital
New York
– -$206K -15,787 Closed
CM
231
Caption Management
Oklahoma
– -$196K -15,000 Closed
DTL
232
Dynamic Technology Lab
Singapore
– -$196K -14,990 Closed
AG
233
Algert Global
California
– -$170K -13,024 Closed
RWA
234
Redhawk Wealth Advisors
Minnesota
– -$159K -12,200 Closed
CM
235
Capula Management
Cayman Islands
– -$156K -11,925 Closed
CMBA
236
C.M. Bidwell & Associates
Hawaii
– -$83K -6,360 Closed
Lazard Asset Management
237
Lazard Asset Management
New York
– -$51K -3,921 Closed
PCM
238
Penserra Capital Management
California
– -$48K -3,725 Closed
Bank of Montreal
239
Bank of Montreal
Ontario, Canada
– -$20K -1,532 Closed
DFCM
240
Dark Forest Capital Management
Puerto Rico
– -$15K -1,119 Closed
Baillie Gifford & Co
241
Baillie Gifford & Co
United Kingdom
– -$12K -935 Closed
TWA
242
TCI Wealth Advisors
Arizona
– -$6K -452 Closed
CFA
243
Carroll Financial Associates
North Carolina
– -$3K -252 Closed
CFA
244
Cahill Financial Advisors
Minnesota
– -$3K -219 Closed
CAGAS
245
Capital Advisory Group Advisory Services
Minnesota
– -$2K -143 Closed
Rockefeller Capital Management
246
Rockefeller Capital Management
New York
– -$1K -128 Closed
QCG
247
Quadrant Capital Group
Ohio
– -$982 -80 -78%
CI
248
Cordant Inc
Oregon
– -$1K -78 Closed
GKWIM
249
Gerber Kawasaki Wealth & Investment Management
California
– -$2K -2 Closed
SC
250
Schubert & Co
Texas
– +$221 +18 New
7 8 9
10
11

IRWD Hedge Fund Activity: Q4 2021 in Review

212 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q4 2021, worth a combined $2B — down 14% from $2.31B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of IRWD and 30 opened new positions — a net loss of 13 holders — while 78 trimmed existing stakes and 70 added.

The largest buyer was BlackRock, adding an estimated $23.3M. The largest seller was Camber Capital Management, cutting an estimated $30.7M.

  • 212 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q4 2021, down from 227 in Q3 2021.
  • Funds reported $2B of Ironwood Pharmaceuticals stock for Q4 2021, down 14% quarter-over-quarter.
  • 30 funds opened new Ironwood Pharmaceuticals positions in Q4 2021 and 43 closed out, a net change of -13 holders.
  • The largest Ironwood Pharmaceuticals buyer in Q4 2021 was BlackRock, an estimated $23.3M added.
  • The largest Ironwood Pharmaceuticals seller in Q4 2021 was Camber Capital Management, an estimated $30.7M sold.

Based on aggregated 13F filings for Q4 2021.